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ABSTRACT 
Koek, W., and J.H. Woods: Partial generalization in pigeons trained to discriminate 
morphine from saline: Applications of receptor theory. Drug Dev. Res. 16:169-181, 1989. 
In pigeons trained to discriminate 5.6 mgikg of morphine from saline, cyclazocine, 
I-N-allyl-normetazocine (I-NANM, I-SKFlO,O47), and ketamine, but not U50,488, produced 
partial generalization, i.e., a maximum level of drug-appropriate responding between the 
levels produced by saline and by the training drug. The generalization gradient of 
cyclazocine and of I-NANM, but not that of ketamine, was less steep than the gradient of 
morphine. Cyclazocine and I-NANM, but not U50,488 and ketamine, antagonized partially 
the discriminative stimulus (DS) effects of morphine. Naltrexone antagonized the DS effects 
of morphine, cyclazocine, and I-NANM, but not ketamine. Increasing the training dose of 
morphine shifted the morphine gradient to the right, increased the antagonist effects of 
cyclazocine and of I-NANM, and decreased their agonist effects, but did not alter the effects 
of ketarnine. Decreasing the training dose of morphine shifted the morphine gradient to the 
left and increased the agonist effects of cyclazocine, but did not alter the effects of I-NANM 
and ketamine. The full generalization produced by cyclazocine when the training dose of 
morphine was lowered could be blocked completely by naltrexone and I-NANM, but not by 
ketamine. These results suggest that cyclazocine and I-NANM, but not ketamine, produced 
partial generalization because of their low efficacy at the receptor that underlies the DS 
effects of morphine. However, the results obtained with ketamine suggest that partial 
generalization may also be produced through other mechanisms. 
Key words: drug discrimination, partial agonist, efficacy, opioids, phencyclidine, cyclazocine, 
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INTRODUCTION 
In a typical drug discrimination procedure. animals are trained to emit one response 
following the administration of a drug and a different response following the administration of 
saline. In general. animals will emit drug-appropriate responses only when tested with novel 
compounds that are pharmacologically similar to the training drug. For example, morphine- 
trained animals will typically show full drug-appropriate responding only when tested with 
other opioids. Certain test drugs, however, produce some, but not full, drug-appropriate 
responding. Such drugs are said to produce partial generalization, i.c.,  a maximum level of 
drug-appropriate responding between the levels produced by saline and by the training drug. 
Receptor theory has guided the analysis of partial generalization data [e.g., Colpaert et al., 
1982; Colpaert and Jansscn, 1984; Holtzman, 1983; Woods et al., 19881. 
According to receptor theory [e.g., Kenakin, 19871, drugs have two basic properties: the 
ability to bind to receptors, referred to as affinity, and the ability to stimulate receptors, 
variously referred to as intrinsic activity, efficacy, or intrinsic efficacy. Partial generalization 
can conceivably result from: 1) low efficacy at the receptor that underlies the discriminative 
stimulus effects of the training drug; 2) actions at other receptors; or 3) nonreceptor-mediated 
actions. It may be helpful to assume initially that drugs produce partial generalization because 
they possess less efficacy than the training drug [e.g., Culpaert, 1986. 1988; Woods et al., 
19881. In accordance with receptor theory, the following predictions can be derived from this 
assumption: 
1. The generalization gradient of a low-efficacy agonist is less steep than the 
generalization gradient of the training drug. 
2. A low-efficacy agonist partially antagonizes the discriminative stimulus effects of the 
training drug, in thc dose range in which the low-efficacy agonist produces partial general- 
ization when given alone. 
3. The partial generalization produced by a low-efficacy agonist is blocked by a 
competitive antagonist of the discriminative stimulus effects of the training drug. 
4. A low-efficacy drug can be a full agonist, a partial agonist, or an antagonist, 
depending on the sensitivity of the test system. The apparent sensitivity of a drug 
discrimination can be altered by varying the training dose. Increasing the training dose 
decreases the sensitivity to the effects of the training drug and ol' drugs that produce full 
drug-appropriate responding; conversely, decreasing the training dose increases the sensitivity 
of the discrimination [e.g., Colpaert et al., 1980; Holtzman, 1982; Koek and Slangen, 19821. 
Therefore a low-efficacy agonist will produce less generalization and more antagonism of the 
effects of the training drug as the training dose is increased, and will produce more 
generalization and less antagonism of the training drug as the training dose is decreased. 
5. The discriminative stimulus effects of a low-efficacy agonist can be blocked by 
another, less efficacious agonist. 
Cyclazocine produces partial generalization in morphine- and in fentanyl-discriminating 
animals [e.g., Holtzman, 1983; Colpaert and Janssen, 1984; Paule and Wenger, 19861. In 
agreement with the assumption that cyclazocine produced partial generalization because of its 
low eflicacy at the receptor that mediates the discriminative stimulus effects of morphine and 
of fentanyl, this partial generalization has been shown to have some of the above-mentioned 
characteristics. To replicate and extend these findings, we studied the ability of cyclazocine to 
produce partial generalization in pigeons that were trained to discriminate between morphine 
and saline and tested each of the five aforementioned predictions. 
In addition to cyclazocine, the selective kappa-opioid receptor agonist U5O,488, the 
I-isomer of N-allyl-normetazocine (NANM, SKF10,047) and the phencyclidine (PCP)-like 
drug, ketamine , were studied: 1 )  to explore whether they also produced partial generalization; 
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and 2) to analyze thcir partial generalization effects, if any, by testing the aforementioned 
predictions. U50,488 and ketamine were included because they havc been reported to produce 
partial generalization in morphine-discriminating pigeons [Essman and Woods, 1986; Herling 
et al., 19801; 1-NANM was included because preliminary experiments suggested that it 
produced substantial, but less than maximal, morphine-appropriate responding. 
MATERIALS AND METHODS 
Subjects 
Six experimentally naive White Carneaux pigeons (Palmetto, Sumtcr, SC) were housed 
individually with water and grit freely available and were maintained at 80% of their 
free-feeding weight by providing mixed grain in the home cage after each experimental 
session. 
Apparatus 
Six ventilated, sound-attenuated chambers measuring 36 X 28 x 33 cm werc used. 
Three translucent responsc keys, 2.4 cm in diameter, were located on thc inside of one wall, 
25 cm from the chamber floor. The keys were 5 cm from each other and could be 
transilluminated by red 7-W lights located behind the wall. Mixed grain was made available 
for reinforcement by means of a hopper, below the center response key and 10 cm above the 
floor of the chamber. A Texas Instruments Inc. (Dallas, TX) 960A computer, located in an 
adjacent room, was used for programming and data collection. 
Procedure 
After autoshaping of a key-peck response, the pigeons were trained to discriminate an 
IM injection of 5.6 mgikg of morphine from saline. Training sessions were conducted 7 
daysiweek. Each session was preceded by an injection of either the training drug or saline, 
after which the pigeon was placed in the experimental chamber. After 10 min, during which 
the chamber was dark and key-peck responses had no programmcd consequences, the house 
light came on, and the left and the right key werc illuminatcd rcd. During the first two to three 
sessions saline was administercd, and responses on thc right key resulted in 4-sec access to 
mixed grain, according to a rcinforcement schedule that was gradually changed from fixed 
ratio (FR) 1 to FR 20. The key lights were off during food presentation, and a white light 
illuminated the hopper. A session ended after SO reinforcements, or after I h, whichever 
occurred first. During the next two to three sessions the training drug was administered, 
responses on the left key were reinforced, and the reinforcement schedule was changed from 
FR 1 to FR 20. Thereafter, drug and saline sessions alternated according to a double- 
alternation sequence. Twenty responses on the injection-appropriate key (i.e., left key 
drug-appropriate, right key saline-appropriate) resulted in reinforcement. Responses on the 
inappropriate key had no programmed consequences. Training was continued until less than 
five responses were made on the injection-inappropriate key, before the first food presentation, 
during ten consecutive sessions. When this training criterion was met, test sessions (Tj and 
drug (D) and saline (Sj training sessions were conducted according to two sequences 
(alternating weekly): S-D-T-S-T-D-T and D-S-T-S-T-D-T. A test session ended, without 
reinforcement. when 20 responses had been mado on either key, or after 1 h, whichever 
occurred first. The key on which 20 responses accumulated first was defined as the selected 
key [i.e., drug key (DK) or saline key (SK)]. 
Tests were conducted only if the injection-appropriate key was selected during both the 
immediately preceding drug training session and saline training session; otherwise drug and 
saline training sessions were alternated until the appropriate key was selected during two 
consecutive sessions. 
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Different doses of morphine and of cyclazocine were tested twice, in the following 
order: morphine-cyclazocine-morphine-cyclazocinc. Next, the ability of naltrexone to 
antagonize DK selection produced by the training dose of morphine (i.e,,  5.6 mgikg) was 
evaluated by injecting different doses of naltrexone 15 niin before the injection of 5 .6  mgikg 
of morphine. In addition. I-NANM, ketamine, US0,488. and naltrexone were testcd for their 
ability to produce DK selection, and cyclazocine, I-NANM, ketamine, and U50,488 were 
tested for their ability to antagonize DK selection produced by the training dose of morphine. 
Finally, the effects of naltrexone on cyclazocine-, I-NANM-, and ketarnine-induced DK 
selection were tested. At this point in the study, one of the pigeons died. 
In two of the remaining five pigeons, the training dose of morphine was increased from 
5.6 to 10 nigikg and. after the discrimination criterion was met, was increased further to 18 
mgikg. In the other three pigeons, the training dosc of morphine was lowered from 5.6 mgikg 
via 3 . 2  mg/kg to I .8 mgikg. Pigeons that discriminated 18 mgikg of morphine were tested with 
morphine, were tested (with naltrexone as a pretreatment to morphine) and were tested with 
cyclazocine, 1-NANM, and ketamine alone and as pretreatment to morphine. Jn the pigeons 
that discriminated 1.8 rngikg of morphine, different doses of morphine: cyclazocine, 
I-NANM, and ketarnine were tested for their ability to produce DK selection, and naltrexone 
was tested for its ability to antagonize morphine-induced DK selection. Cyclazocine produced 
100% DK selection in pigeons trained to discriminate 1.8 mgikg of morphine from saline; 
subsequently, the ability of naltrexone. I-NANM, and ketamine to antagonize this effect of 
cyclazocine was studied. 
Data Analysis 
The percentage of DK sclections was used as a measure of training drug-like 
discriminative stimulus effects. To evaluate parallelism of dose-effect curves, a line was fitted 
by linear regression to log dose ~ % DK selections data for each drug, and the statistical 
significance of slope differences was assessed, using the methods described in Tallarida and 
Murray 119811. 
The incidence of D K  selection was defined as follows: number of DK selections/ 
(number of doses tested times number of replications). For each pigeon, the incidence of DK 
selection produced by cycluocinc. I-NANM, and ketamine was calculated. For each of these 
drugs. the incidence of DK selection was assessed when the drug was administered alone and 
when it wa5 administered after naltrexone (0.32 and 10 rngikg). The Friedman teSt [Siegel, 
19561 was used to evaluate the statiqtical significance of the cffects of naltrexone 011 the 
incidence of DK selection. 
Selection latency was defined as the tinie (in sec) between the illumination of the 
response key5 and thc occurrence of key selection. Selection latencies were log-transformed 
prior to statistical analysis by one-factor (i.e., dose) repeated measures analysis of variance 
[Winer. 19711. Post hoc comparisons were made using Dunnett’s t test. 
Drugs 
The compounds used were morphine sulfate, naltrexone hydrochloride, d l  xyclazocine, 
1 -N-allylnormetazocine hydrochloride. ketamine hydrochloride, and USO,488 methancsul- 
phonate hydrate. dl-Cyclazocine was dissolved in distilled water acidified with lactic acid; all 
other drugs were dissulved in sterile water. Doses are expressed in the forms described above. 
RESULTS 
Generalization 
Morphine (5.6 mgikg) acquired discriminative control over responding in all pigeons; 
the geometric mean of the number of sessions to criterion (GM-STC) was 55 .  The accuracy of 
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Fig. 1 .  Discriminative stimulus effects of morphine, naltrexone, U50.488, d I-cyclazocine, I-N-allyl- 
normetazocine (I-NANM), and ketamine alone (e) and combined with the training dose (0) in pigeons (n 
= 6) trained to discriniinatc betwcen injections of 5.6 m g k g  of morphine and of saline. Data points that 
are marked with an ‘‘a’’ were obtained at doses that significantly increased the mcan kcy-selection 
latency. Doses of morphine and of dl-cycla~ocine when given alone were tested twice. Ordinates: 
percentage o f  morphine-key selections; ahscissae: IM dose administered (mgikg), 10 min before the start 
wf the session (0) or 15 rnin before thc injection of 5.6 iiigikg of morphine 0). 
the postcriterion discrimination performance was not significantly different between drug and 
saline sessions (P > 0.05), the mean percentage of correct key selections (? 1 SEM) being 
92 -t I .  
Morphine exerted dose-dependent effccts on the percentage of DK selections (Fig. I). 
Although the percentage of DK selcctions was dose-dependently increased by cyclazocinc, by 
I-NANM, and by ketamine, each of thesc drugs produced a maximum percentage of DK 
selections lower than that produced by morphine. Cyclazocine produced a maximum of 45% 
at a dose of 3.2 mgikg, ketamine produce a maximum of 67% at 10 mgikg, and I-NANM 
produced 40% DK selections at 18 mglkg. Cyclazocine was tested twice and produced DK 
selection in all pigeons during the first and/or the second test. I-NANM and ketaniine were 
tested once and produced DK selection in three and in four of the six pigeons, rcspectively. 
The log dose-DK selection data obtaincd with morphine, cyclazocine, I-NANM, and 
ketamine could be fitted adequately by straight lines (the correlation coefficients ranged from 
0.84 to 0.99). For each of the drugs. all data were includcd in the regrcssion analysis. The 
slope of the regression line, indicating the amount by which the percentage of DK selections 
increased per 1 log unit increase of dose, was 87 for morphine. The slope value for cyclazocine 
(i.e., 23) was significantly lower than the slope value for morphine ( P  < 0.05). The slope 
value for I-NANM (1 1 )  was significantly lower than the slope valuc for cyclazocine ( P  < 
0.05). However, the slope value for ketamine (76) was not significantly different from the 
slope value for morphine. US0,488 produced exclusively SK selection. The geometric mean 
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key selection latency (GM-KSL) was significantly increased from 10 sec (after saline) to 200 
sec by 3.2 mgikg of cyclazocine, to 72 and 933 sec by 10 and 18 mgikg of 1-NANM, 
respectively, and to 51 and 1,122 sec by 10 and 18 mgikg of ketamine, respectively ( P  < 
0.05). Note that ketamine produced DK selection exclusively at doses that increased the key 
selection latency, unlike the other drugs tested. 
Antagonism 
Naltrexone completely antagonized the effects of the training dose of morphine, at a 
dose (0.32 mgikg) that failed to induce DK selcction when given alone. Whcrcas cyclazocine 
and 1-NANM dose-dependently antagonized the effects of the training dose of morphine, the 
antagonism was less than maximal in that the percentage of DK selections was not reduced 
further than to 50%. The log dose-DK selection data obtained with naltrexone, with 
cyclazocine, and with I-NANM as pretreatment to the training dose of morphine were fitted 
adequately by straight lines. The slope value of the regression line was -47 for naltrexone, 
-26 for cyclazocine, and ~ 12 for I-NANM. The slope of the regression line describing the 
1-NANM data was significantly lower than the slope value obtained with naltrexone ( P  < 
0.05). Neithcr ketamine nor U50,488 reduced the percentage of DK selections in a monotonic, 
dose-dependent manner. 
Antagonism of Partial Generalization 
The effect of naltrexone on the incidence of DK selection produced by cyclazocine 
approached statistical significance ( P  < 0.06), as did the effect of naltrexonc on I-NANM- 
induced DK selection ( P  < 0.09). At a dose of 10 mgikg, naltrexone reduced the ability of all 
but the highest dose of cyclazocine and of 1-NANM to produce DK selection (Fig. 2). The 
incidence of DK sclcction observed aftcr ketamine was not significantly affected by naltrexone 
( P  > 0.50). 
The lowcst dose that significantly increased the key selection latency was 3.2 mgikg for 
cyclazocine, 10 mgikg for I-NANM, and 10 mgikg for ketarnine. Naltrexone (0.32 and 10 
mgikg) failed to block significantly the selection latency-increasing effects of' cyclazocinc, 
1-NANM, and ketamine (P > 0.10). Note that, in general, naltrexone blocked DK selection 
primarily when DK selection was produced by doses that did not increase the key sclection 
latency. 
Antagonism in High-Training-Dose Pigeons 
The two pigeons for which the training dose of morphine was increased from 5.6 to 18 
nigikg met the discrimination criterion at a dose of 10 mgikg after 14 (pigeon 1 )  and 0 (pigeon 
2) STC. They met the criterion aftcr 0 STC as the training dose was increased further to 18 
mgikg. The mean percentage ofcorrcct key selections was 100, both during postcriterion drug 
sessions and saline sessions. 
By incrcasing the training dose from 5.6 to 18 mgikg, the dose-effect curve of morphine 
was shifted to the right (Fig. 3), in a parallel manner. (The slope values were not significantly 
different.) The 18 mgikg training dose of morphine significantly increased the GM-KSL from 
17 to 52 sec ( P  < 0.05). Naltrexone antagonized completely the effects of 18 mgikg of 
morphine. In the presence of 0.032 mgikg of naltrexone, 18 mgikg of morphine produced 
neither DK selection nor an increase of the key selection latency. The effects of 18 mgikg of 
morphine were antagonized also by cyclazocine and by I-NANM, but not by kctamine. The log 
dose-DK selection data obtained with naltrexone, cyclazocine, and 1-NANM as pretreatment 
to the 18-mgikg training dose of morphine were fitted adequately by straight lines. The slope 
values of the regression lines were not significantly different. The antagonist effects of 
cyclazocine were enhanced in the 18-mg/kg-trained pigeons. but remained less than complete: 
whereas 0.1 mgikg of cyclazocine decreased the percentage of DK selections produced by the 
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Fig. 2. Discriminative stiiriulus effects of dl-cyclazocine, I-N-allyl-normetazocine (I-NANM), and 
ketaminc alone (small filled circles, replotted from Fig. 1) and 15 Inin after the injection of 0.32 mgikg 
(open circles, upper panels) or 10 mgikg (large filled circles, lower panels) of naltrexone. in pigeons 
(n = 6) trained to discriminate between injections of 5 .6  mg!kg of morphine and of saline. Data points 
that are marked with an "a" were obtained at doses that significantly increased the mean key-selection 
latency. Ordinatcs: percentage of morphine-key selcctions: abscissae: IM dose administered (mgikg), 10 
min before the start of thc test session. 
5.6-mg/kg training dose of morphine from 100 to 83, this dose of cyclazocine decreased the 
effects of the 18-mgikg training dose of morphine from 100 to 25%. In the dose-range in which 
cyclazocine produced antagonism, it produced a maximum of 25% DK selections when given 
alone. Whereas I-NANM antagonized the effects of the training dose of5 .6  mgikg of morphine 
only partially, I-NANM acted as a complete antagonist of 18 mgikg of morphine. In the dose 
range in which I-NANM produced complete antagonism, it failed to induce any DK selection 
when given alone. However, 1-NANM produced a maximum of 50% DK selections at a higher 
dose (i.e., 10 mg/kg) that increased the selection latency. Ketamine produced 50% DK 
selections in the 18-mgikg-trained pigeons and failed to antagonize the discriminative stimulus 
effccts of 18 mg!kg of morphine. 
Generalization in Low-Training-Dose Pigeons 
All three pigeons for which the training dose was decreased reached the discrimination 
criterion both at 3.2 mg/kg (GM-STC = 7) and at 1 .8 mg/kg of morphine (GM-STC = 15). 
However, due to time limitations, the planned tests could not be conducted in the pigeon that 
reached criterion last. In the remaining two pigeons, the mean percentage of correct key 
selections was 96 * 2 and 83  2 12 during postcriterion saline sessions and drug sessions, 
respectively . 
By decreasing the training dose from 5.6 to 1.8 mgikg the dose-eff'ect curve of morphine 
was shifted to the left (Fig. 4). in a parallel manner. Naltrcxone antagonized thc effects of I .X 
mg/kg of rnorphinc at a dose that was lower than the dose needed to antagonize the effects of 
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Fig. 3. Discriminative stiniulus effects of morphine, naltrexone, d 1 -cyclamcine, I-N-allyl- 
normetazocinc (I-NANM), and kctaniinc alone (filled symbols) and combined with the training dose 
(open symbols) in pigeons (n = 2) trained t o  discriminate between injections of 18 mgikg o i  morphine 
(circles) and in pigeons (n = 6 )  trained to discriminate between in,jections of 5.6 mg/kg of morphine and 
of saline (squares: replotted from Fig. 1) .  In the two pigeons that were trained to discriminate 18 mg:kg 
of morphine from saline. each dose was tested twice. Data points that are marked with an ‘‘a” were 
obtained at doses that significantly increased the mean key-aelectian latency. Ordinates: percentage of 
morphine-key selections: abscissae: IM dose administered (mg:kg). 10 min before the htart of the sesbion 
(filled symbols) or 15 min before the injection of the training dose of morphine (open symbols). 
5.6 mgikg of morphine. In the 1.8-mgikg-trained pigeons, the percentage of DK selections 
was increased dose-dependently by cyclaaocine, by LNANM, and by ketamine; the data 
obtained with these drugs could be fitted adequately by straight lines. The slope values ror 
cyclazocine and for ketaminc were not significantly different from the slope value for 
morphine. The slope valuc for I-NANM was significantly lower than the slope value for 
cyclazocine. The maximum percentage of DK selections produced by cyclazocine was 
increased to its maximum possible value: whereas 1 mgikg of cyclazocinc did not produce 
morc than 33% DK selections when the training dose was 5.6 mg/kg, it produced 100% DK 
selections when the training dose was 1.8 ingikg. Note that 1 ingikg of cyclazocine did not 
significantly affect the key selection latency. In contrast to cyclazocine, neither the ability of 
1-NANM nor of ketamine to produce DK selection was increased by a lowcring of the training 
dose from 5.6 to 1.8 mgikg of inorphinc. 
Antagonism of Full Generalization Produced by Cyclazocine in 
Low-Training-Dose Pigeons 
Naltrexone blocked dose-dependently and completely the ability of cyclazocine to 
produce 100% DK selections in 1 .g-mg/kg-trained pigeons (Fig. 5 ) .  The dose of naltrexone 
that produced complete antagonism (0.32 mgikg) was higher than the dose needed to 
antagonize completely the effects of the 1 .8-mg/kg training dose of morphine (0.01 mg/kg; 
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4. Discriminative stimulus effects of morphine, naltrexone. d I-cyclamcine, I-N-allyl- 
noi.metazocine (I-NANM), and ketarnine alone (filled symbols) and combined with the training dose 
(open symbol>) in pigeons (n 2 )  trained to discriminate betwcen injections of 1.8 m g i k g  of morphine 
and of saline (circle.;) and in pigeons (n = 6) trained to discriminate between injections of 5.6 mgikg of 
morphine and of d i n e  (squares; replotted froin Fig. I J. In the pigeons that were trained to dixrirninate 
1.8 mg!kg ot inorphinc from salinc. cach dose was tcstcd twice in cach pigcon, except for doses of 
naltrexone that were tehted twice in one pigeon and once in the other pigeon. Data points that are marked 
with an "a" were obtained at doses that significantly increased the mean key-selection latency. Ordinates: 
percentage of niorphinc-key sclections; abscissae: IM dosc administered (mglkg), 10 min bcforc the start 
of the session (filled symbols) or 15 min herore the injection of the training done o f  morphine (open 
sym hols). 
Fig. 4). Furtherniore, the slope of the regression line describing the cyclazocine-antagonist 
eflects of naltrexone was significantly shallower than the slope of the morphine-antagonist 
effects of naltrexone. The ability of cyclamcine to produce 100% DK selections in 
1 .X-mgikg-trained pigeons was antagonized also by I-NANM. in  a dose-dependent and 
complete manner. I-NANM failed to completely antagonize cyclazocine at a higher dose that 
produced DK selection and increased the key selection latency when given alone. The slope 
value of the regression line describing the antagonism of cyclaxocine by I-NANM was not 
significantly different from the slope value for naltrexone. Ketainine blocked only partially the 
discriminative stimulus effects of cyclazocine, when tested up to a dose that increased the key 
selection latency. 
DISCUSSION 
Cyclazocine produced partial generalization in morphine-discriminatinp p'c i reons. a 
finding that replicates and extends previcius observations [e.g., Holtzman, 1983: Colpaert and 
Janssen. 1984; Paule and Wenger, I%6]. The selective kappa opioid agonist U50,488 fizilcd 
to produce any morphine key selection. Although initial results obtained with kappa agonists 
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Fig. 5 .  Discriminative atimulus effects of dl  -cyclaxocine, naltrexone, I-N-allyl-normctazocinc (1- 
NANM), and kctamine alonc (0 )  and combined with 1 nigikg of dl-cyclazocine (0) in pigeons (n  = 2) 
trained to discriminate between injections o f  I .8 mgikg of morphine and saline. Each dose was tested 
twice in  one pigcon and once in the othcr pigeon. Data points that are marked with an “a” were obtained 
at doses that significantly increased the mean key-selection latency. Ordinates: percentage of niorphine- 
key selections; abscissae: IM dose administered (mg/kg), 10 rnin before the start of the session (*) or 15 
min before the injection of 1 rngikg of dl-cyclamcine (0). 
that were less selective than US0,488 indicated that the pigeon may not be ablc to discriminate 
between mu and kappa agonists [Herling and Woods, 19811, more rcccnt results show greater 
differentiation IPicker and Dykstra, 19871, in agreement with the results of the present study. 
Like cyclazocine, both I-NANM and the PCP-like compound kctamine produced partial 
generalization, in agreement with previous findings in morphinc-discriminating pigeons 
[unpublished observations; Herling et a l . ,  19801. 
For cyclazocine, 1-NANM, and kctamine, several predictions, derived from receptor 
theory, were tested to evaluate the hypothesis that low efficacy at the receptor that mediates 
the discriminative stimulus effects of the training drug underlies their partial generalization 
effects. 
The generalization gradient of cyclazocine was less steep than the generalization 
gradient of morphine. The gradicnt of I-NANM was shallower than the gradient of 
cyclazocine. These findings suggest that cyclazocine is less efficacious than morphine and that 
I-NANM is less efficacious than cyclazocine at the receptor that under1 ies morphine’s 
discriminative stimulus effects. However, the finding that the slope of the ketamine gradient 
was not significantly different from the slope of the morphine gradient is not in agreement with 
the hypothesis that ketamine is a low-efficacy agonist at this receptor. 
A low-efficacy agonist should partially antagonize the discriminative stimulus effects of 
the training drug, in the dose range in which it produces partial agonism. This prediction was 
verified for cyclazocine and for I-NANM, but not for ketamine. 
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The discriminative stimulus effects of a low-efficacy agonist should be blocked by an 
antagonist. Naltrexone appeared to block the generalization produced by cyclazocine and by 
1-NANM. However, antagonism was not complete and occurred only at a dose that was higher 
than thc dose needed to block the effects of morphine. This observation may be consistent with 
receptor theory. The dose-effect curves of a full and of a partial agonist should be shifted an 
equal amount to the right when combined with the same antagonist. However, the dose-effect 
curve of a partial agonist is shallower than the dose-effect curve of a full agonist. If, for 
example. the slope of the dose-effect curve oT a partial agonist is ten times less steep than the 
slope of the dose-effect curve of a full agonist, the lowest dosc of an antagonist that reduces 
the maximum effect of the full agonist by 100% reduces the maximum effect of the partial 
agonist by only 10%. Such small reductions of the level of drug-appropriate responding may 
be difficult to detect reliably, under the conditions of the present experiment. Naltrexone failed 
to block the effects of ketamine and did not block completely the effects of those doses of 
cyclazocine and of 1-NANM that increased selection latency. 
In accordance with receptor theory, decreasing the apparcnt sensitivity of the discrim- 
ination by increasing the training dose of morphine affected the agonist and antagonist effects 
of cyclazocine and of 1-NANM: both drugs had more antagonist activity and less agonist 
activity in the dose range in which antagonism was obscrvcd. Beyond that dose range, 
however, I-NANM still produced substantial generalization, albeit at selection latency- 
increasing doses. At the higher training dose of morphine, ketamine did not show antagonist 
activity, but did show agonist activity at selection latency-increasing doses, similar to its 
effects at the original training dose. Naltrexone completely antagonized the effects of the 
higher training dose of morphine. 
By decreasing the training dose, the apparent sensitivity of thc morphine discrimination 
was increased. Naltrexone completely blocked the discriminative stimulus effects of the 
lowered training dose of morphine. The antagonism occurred at lower doses of naltrexone, 
further evidencing the increased sensitivity of the discrimination. As the training dose of 
morphine was lowercd, thc agonist effects of cyclazocine increased, i.e., cyclazocine 
produced full morphine-appropriate responding that could be blocked completcly by nal- 
trexone. However, the agonist effects of 1-NANM and of ketamine were not detectably 
affected by the decrease of the training dose. In the initial part of this study, 1-NANM produced 
partial gcncralization along a gradient that was shallower than the gradient of cyclamcine, 
unlikc ketaminc. Furtherrnorc, as the training dose was increased, I-NANM showed less 
agonist and more antagonist activity than cyclazocine, unlike ketamine. These observations 
together suggest that I-NANM. but not ketaniine, has lower efficacy than cyclazocine at the 
receptor that underlies the morphine discrimination. Although the sensitivity of the discrim- 
ination was increased sufficiently for cycla7ocine to produce full generalization, the incrcase 
may not have been sufficiently large to enable I-NANM to produce a higher level of agonist 
activity. 
If 1-NANM has lower cfficacy than cyclazocine, I-NANM should block the discrimi- 
native stimulus effects of cyclazocine. Indeed, the full gencralization observed with cyc la~o-  
cine in pigeons trained to discriminate a lowered dose of morphine from saline was 
antagonized completely by I-NANM. Beyond the dose range in which a complete blockade 
was observed, I-NANM failed to act as a full antagonist of cyclazocine and increased thc 
selection latency. Ketamine antagonized thc effects of cyclazocine only partially, and only at 
a dose that increased the selection latency. 
Tdkcn together. the results suggest that cyclazocine and 1-NANM produce partial 
generalization in morphine-discriminating pigeons bccausc they have a lower efficacy than 
morphine at the receptor that underlies the discriminative stimulus effects of morphine. 
Furthermore, the efficacy of I-NANM appears to be lower than thc cfficacy of cyclaLocine. 
However. thc partial generalization observed with kctamine appears to be based on a different 
mechanism, because: 1) the slope of the ketamine gradient i s  not shallower than the slopc of 
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the morphine gradient; 2) the partial generalization could not be blocked by naltrexone; 
3) ketamine failed to antagonize morphine. even as the training dose of morphine was 
increased; 4) kctamine did not produce more drug-appropriate responding as the training dose 
of morphine was decreased; 5) ketamine failed to antagonize the effects of cyclazocine; and 6) 
the agonist effects of ketaniine occurred only at selection latency-increasing doses. These 
results suggest that partial generalization may occur in morphinc-discriminating animals 
through mechanism that perhaps cliller from the receptor mechanism underlying the 
discriminative stimulus effects of morphine. Indeed, this different, nonopioid mechanism may 
be responsible not only for the morphine-appropriate responding produced by kctamine, but 
also for the morphine-appropriate responding produced by selection latency-increasing doscs 
of cyclazocine and of I-NANM, because the agonist effects of thcsc doscs wcre not blocked 
completely by naltrexone and did not decrease as the training dose was increased. Conceiv- 
ably, a disruption of discriminative behavior may result in intermediate levels of drug- 
appropriate responding [e.g. Koek and Slangen. 19841. Given that cyclazocine, I-NANM, 
and ketamine all have PCP-like behavioral e f fc t s  [e.g., they all substitute completely for PCP 
in PCP-discriminating pigeons (Koek and Woods, unpublished observations)] and given the 
ability of PCP-likc drugs to reduce thc accuracy of discriminative bchavior [c.g., Kock and 
Woods, 1986; Moerschbaecher et a l . ,  1984: Picker and Dykstra. 19881. it may be suggested 
that partial generalization: at selection latency-increasing doses, is perhaps caused by a 
disruption of discriminative bchavior. 
In summary, the results obtained here agree with the suggestion that partial general- 
ization indicates a low efficacy at the receptor that mediates the discriminative stimulus cffects 
of the training drug [Colpaert, 1986, 1988; Colpaert and Janssen, 1984; Holtzman, 1983; 
Holtzrnan and Lockc, 1988; Woods ct al.,  19881, with the restriction. however, that partial 
generalization niay perhaps bc produced also through other. less well-characterized mecha- 
nisms. Preliminary results suggest that PCP-like drugs may produce partial generalization not 
only in morphine-discriminating pigeons, but also in fentdriyl-discrirninating rats [Koek and 
Colpaert, unpuhlished observations]. In conclusion, the results presented here stress the 
importance of a detailed analysis of partial generaliLation effects. guided by receptor theory, 
to establish their underlying mechanism. 
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